Nxera Pharma: Confirmatory letter.
Nxera Pharma: Interim report - 35th period (01/01/2024 - 12/31/2024)
Nxera Pharma: Business highlights and consolidated performance for the second quarter (interim period) of December 2024 (January-June).
Nxera Pharma: December 2024, second quarter (interim period) financial results announcement [IFRS] (consolidated).
Sosei Group: Confirmation letter
Sosei Group: Quarterly Report - 35th Quarter 1 (2024/01/01 to 2024/03/31)
Sosei Group: Business highlights and consolidated financial results for the first quarter (January-March) of the fiscal year ending 2024/12
Sosei Group: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
Sosei Group: Extraordinary Report
Sosei Group: Confirmation
Sosei Group: Financial Report - 34th Term (2023/01/01 - 2023/12/31)
Sosei Group: Business highlights and consolidated financial results for the fiscal year ending 2023/12 (January-December)
Sosei Group: Notice regarding differences between consolidated results for the fiscal year ending 2023/12 and consolidated results for the previous fiscal year and recording of financial expenses
Sosei Group: Summary of financial results for the fiscal year ending 2023/12 [IFRS] (Consolidated)
Sosei Group: Interim Report of Corrections
Sosei Group: Extraordinary Report
Sosei Group: Confirmation letter
Sosei Group: Quarterly Report - 34th Third Quarter (2023/07/01 - 2023/09/30)
Sosei Group: Business highlights and consolidated results for the third quarter (January-September) of the fiscal year ending 2023/12
Sosei Group: Summary of Financial Results for the 3rd Quarter Ending December 31, 2023 [IFRS] (Consolidated)
No Data
No Data